[Fertility disorders attributable to the use of diethylstilbestrol during intrauterine life].
A lot has been written about the abnormalities seen in children born to women treated with distilbene during pregnancy. The author reviews the current state of the certainties and the doubts. It seems that the increased number of miscarriages, extra-uterine pregnancies and perinatal deaths are probably due to the maternal treatment which is also responsible for semen abnormalities.
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000022:Abortion, Spontaneous / Q000453:epidemiology; D004054:Diethylstilbestrol / Q000009:adverse effects*; D005260:Female; D005313:Fetal Death / Q000453:epidemiology; D005836:Genitalia, Female / Q000002:abnormalities*; D005837:Genitalia, Male / Q000002:abnormalities; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007247:Infertility, Female / Q000139:chemically induced*; D007248:Infertility, Male / Q000139:chemically induced*; D008297:Male; D008599:Menstruation Disturbances / Q000139:chemically induced; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D013076:Sperm Count; D013084:Sperm-Ovum Interactions
D004054:Diethylstilbestrol
Les troubles de la fertilité imputables à l'imprégnation par le diéthylstilbestrol pendant la vie intra-utérine.